Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Single and Multiple Doses to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Randomized, Open-label, Food Effect Study of HEC73077 in Healthy Subjects
Conditions
Interventions
HEC73077 tablets
HEC73077 placebo tablets
Locations
1
China
The First Hospital of Jilin University
Changchun, Jilin, China
Start Date
May 24, 2021
Primary Completion Date
January 4, 2023
Completion Date
January 4, 2023
Last Updated
April 12, 2023
NCT06843304
NCT01802034
NCT06833541
NCT06661174
NCT04931537
NCT06954090
Lead Sponsor
Sunshine Lake Pharma Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions